ACIU
LIVE

Serial Number

88636128

Owner

AC Immune SA

Attorney

Kristina Montanaro Schrader

Filing Date

Sep 30, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ACIU Trademark

Serial Number: 88636128 • Registration: 6909260

ACIU is a trademark filed by AC Immune SA on September 30, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AC Immune SA (8 trademarks)

EPFL Innovation Park, building B

Entity Type: 99

Trademark Details

Filing Date

September 30, 2019

Registration Date

November 29, 2022

Published for Opposition

September 14, 2021

Goods & Services

Pharmaceuticals, medical and veterinary preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds, all for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodies, antibody fragments and antibody derivatives for use in disease testing, diagnosis, prevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; PET-Imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in PET imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes

Chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements, namely, chemical preparations for industrial and scientific purposes, other than for medical or veterinary use; chemical, biochemical, biological and biotechnological preparations for use in industry and science; protein, protein fragments, amino acids, antibodies and fragments thereof for industrial, scientific or research purposes, other than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular libraries, comprising libraries of chemical preparations for use in industry and science; small molecule library, comprising libraries of chemical preparations for use in industry and science; antibody library, comprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodies, proteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; biological cell, biological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparations, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use

Scientific and technological services, namely, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, PET-imaging, companion diagnostic biomarkers, antibodies, vaccines and test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; biological research, namely, screening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and development, namely, vaccine and antibody engineering

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 29, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 29, 2022 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 26, 2022 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 26, 2022 AITU
NOTICE OF ALLOWANCE CANCELLED
Oct 10, 2022 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Oct 10, 2022 D1BR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2022 EXRA
SOU EXTENSION 1 GRANTED
May 9, 2022 EX1G
SOU EXTENSION 1 FILED
May 9, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
May 9, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 27, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 27, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 27, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 9, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 14, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2021 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 6, 2021 RCCK
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 13, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 29, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 29, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jul 29, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 2, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 7, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 7, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 7, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2019 NWOS
NEW APPLICATION ENTERED
Oct 3, 2019 NWAP